Porous SiO2-Based Reactor with Self-Supply of O2 and H2O2 for Synergistic Photo-Thermal/Photodynamic Therapy
Zhengzhao Li,Lianshan Guo,Liqiao Lin,Tongting Wang,Yanqiu Jiang,Jin Song,Jihua Feng,Jianfeng Huang,Haoyu Li,Zhihao Bai,Wenqi Liu,Jianfeng Zhang
DOI: https://doi.org/10.2147/IJN.S387505
IF: 7.033
2023-07-03
International Journal of Nanomedicine
Abstract:Zhengzhao Li, 1, &ast Lianshan Guo, 1, &ast Liqiao Lin, 1 Tongting Wang, 1 Yanqiu Jiang, 1 Jin Song, 1 Jihua Feng, 1 Jianfeng Huang, 2 Haoyu Li, 2 Zhihao Bai, 3 Wenqi Liu, 4 Jianfeng Zhang 1 1 Department of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China; 2 Department of Nephrology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China; 3 College of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, China; 4 Department of Radiation Oncology, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China &astThese authors contributed equally to this work Correspondence: Zhihao Bai, College of Chemistry and Chemical Engineering, Guangxi University, Nanning, Guangxi, 530004, China, Tel/Fax +86 771-3237584, Email Jianfeng Zhang, Department of Emergency, The Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530007, China, Tel +86 771- 3277068, Fax +86 771- 3277277, Email Purpose: Although the combined photo-thermal (PTT) and photodynamic therapy (PDT) of tumors have demonstrated promise as effective cancer therapy, the hypoxic and insufficient H 2 O 2 supply of tumors seriously limits the efficacy of PDT, and the acidic environment reduces the catalytic activity of nanomaterial in the tumor microenvironment. To develop a platform for efficiently addressing these challenges, we constructed a nanomaterial of /GOD-MnO 2 -SiO 2 @ (AMS) for combination tumor therapy. The treatment effects of AMS were evaluated both in vitro and in vivo. Methods: In this work, Ce6 and hemin were loaded on graphene (GO) through π-π conjugation, and Fc was connected to GO via amide bond. The was loaded into SiO 2 , and coated with dopamine. Then, MnO 2 was modified on the SiO 2 . Finally, and GOD were fixed to gain AMS. We characterized the morphology, size, and zeta potential of AMS. The oxygen and reactive oxygen species (ROS) production properties of AMS were analyzed. The cytotoxicity of AMS was detected by MTT and calcein-AM/PI assays. The apoptosis of AMS to a tumor cell was estimated with a JC-1 probe, and the ROS level was detected with a 2',7'-Dichlorodihydrofluorescein diacetate (DCFH-DA) probe. The anticancer efficacy in vivo was analyzed by the changes in the tumor size in different treatment groups. Results: AMS was targeted to the tumor cell and released doxorubicin. It decomposed glucose to produce H 2 O 2 in the GOD-mediated reaction. The generated sufficient H 2 O 2 was catalyzed by MnO 2 and to produce O 2 and free radicals (•OH), respectively. The increased oxygen content improved the hypoxic environment of the tumor and effectively reduced the resistance to PDT. The generated •OH enhanced the ROS treatment. Moreover, AMS depicted a good photo-thermal effect. Conclusion: The results revealed that AMS had an excellent enhanced therapy effect by combining synergistic PTT and PDT. Keywords: nanomaterial, photo-thermal therapy, photodynamic therapy, hypoxia Reactive oxygen species (ROS) is an important intracellular signaling molecule in biological processes. 1 At normal concentrations, ROS can regulate cell growth, apoptosis, and differentiation; it also participates in proliferation, DNA damage, and other living activities. However, congestion of the plethora of ROS can lead to oxidative damage and, ultimately, apoptosis. 2 Breaking the ROS content threshold to trigger tumor apoptosis has attracted extensive interest in tumor therapy. 3–5 ROS-based methods have demonstrated considerable potential in cancer therapeutics. 6–8 Photodynamic therapy (PDT), which uses photosensitizers to generate ROS by laser activation, is generally regarded as a scheme for ROS-based tumor therapeutics. 9–11 However, the hypoxic nature of tumor tissue is very harmful to a photosensitizer, which requires oxygen molecules to exert cytotoxicity. In addition, the consumption of O 2 by the photosensitizer will increase the tumor site hypoxia in the PDT process, resulting in a weakening effect of PDT for cancer treatment. 12–15 Many programs have been developed to ameliorate the hypoxic condition to improve the therapeutic effect. 16–20 Using nanomaterials as catalysts to improve the oxygen concentration of tumor sites has attracted increasing interest. 21–23 Some treat -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology